HEXIMA LIMITED.
ASX:HXLPharmaceuticals, Biotechnology & Life SciencesSuspended from quotationToday’s holders own 95.5% of what they think they own, once every option and right converts.
Not rated — the company is suspended from quotation
This company is suspended from ASX quotation. Scoring is paused until it resumes trading. Not rated means no assessment — not low risk.
HEXIMA LIMITED. underwent an approximately 1-for-4 share consolidation in April 2026. The company has no share-issuance filings on record since January 2024. No capital raises have occurred in the past 24 months. Options and rights could convert into 2M new shares, representing 4.7% of the current share count, with the nearest expiry in September 2028. As of June 2026, the company reported A$244K in available cash, sufficient for approximately 14.4 quarters. No proposed securities issues are pending.
Shares on issue — last 2 years
Cash runway
Issuance timeline
Latest 4 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | On issue, per this filing | Source |
|---|---|---|---|---|
| 2 Apr 2025 | 3H · cancellation | HXL : ORDINARY FULLY PAID | 167.0M | Appendix 3H |
| 13 Jan 2025 | 3H · cancellation | HXL : ORDINARY FULLY PAID | 167.0M | Appendix 3H |
| 20 Mar 2024 | 3G · unquoted | HXL : ORDINARY FULLY PAID | 167.0M | Appendix 3G |
| 1 Feb 2024 | 3H · cancellation | HXL : ORDINARY FULLY PAID | 167.0M | Appendix 3H |
Each filing states the count for the security it names, as at its own reference date and in the units of that filing — so the newest row (167.0M) need not equal the current count above (41.8M).
Capital raises
Forward supply
Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.
Placement capacity
How much stock a company can place without asking holders. Listing Rule 7.1 allows 15% of ordinary securities in any 12 months, and every Appendix 3B states how much of it an issue uses.
Pending proposed issues
Options & convertible securities
consolidation-adjusted Figures rebased for the share consolidation on record.
At $0.013 today, 0 securities are in the money (0.0% of shares on issue). No price up to ten times today’s switches on any more priced supply.
- Priced supply in the money at the price on the axis — the curve, and the only thing on it. Ten prices, sampled: between two of them the true figure lies between the two.
- 2.0M more carries an exercise price above ten times today’s — off the right of this axis, and in every total on this page.
| Code | Security | Type | Exercise price | Expiry | On issue | Source |
|---|---|---|---|---|---|---|
| HXLAR | Options | Price-triggered | $0.23 | 4 Sept 2028 | 838k | Filing |
| HXLAJ | Options | Price-triggered | $0.80 | 14 Oct 2030 | 725k | Filing |
| HXLAL | Options | Price-triggered | $0.82 | 27 July 2031 | 271k | Filing |
| HXLAM | Options | Price-triggered | $1.10 | 1 Sept 2031 | 134k | Filing |
“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column.
Director dealings
Ownership
Latest announcements
Headlines link to the source PDFs on the ASX announcements platform. Data as of 12 Sept 2026.